← Back to patent-cliff list
Chloroquine Phosphate Gel(Hybribio Biotech)
Tier C — Watch / tradeChloroquine Phosphate Gel(Hybribio Biotech)
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Updating
Indications (approved)：人乳头瘤病毒感染, 尖锐湿疣, 疣, Viral infection
Regional status
US
-
EU
-
China
Phase II
2021-01-12
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Chloroquine Phosphate Gel(Hybribio Biotech)?
Approved indications include: 人乳头瘤病毒感染, 尖锐湿疣, 疣, Viral infection.
When does the Chloroquine Phosphate Gel(Hybribio Biotech) patent expire?
No public expiry year is available for Chloroquine Phosphate Gel(Hybribio Biotech) yet; this page updates once verified.
How do I get a quote for Chloroquine Phosphate Gel(Hybribio Biotech) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06